Originally developed to manage Type 2 diabetes, Semaglutidea GLP-1 receptor agonist is making waves in nephrology for its ability to support kidney health and slow disease progression
Trans Am Soc Artif Intern Organs 1977
Distributing protein across 46 meals (rather than concentrating it in 12 large meals) may feel more tolerable when appetite is suppressed
However, some patients experience mild ongoing symptoms that are manageable and, in their view, an acceptable trade-off for sustained weight loss
[19] It is available on NHS prescription for adults with a BMI 28 kg/m (with risk factors) or 30 kg/m, alongside dietary and lifestyle measures
Alba AC, Kirklin JK, Cantor RS, Deng L, Ross HJ, Jacobs JP, et al